AseBio calls for a Biotech Act I with greater funding, regulatory agility, and a stronger ... 18/05/2026 We welcome the overall regulatory proposal, but believe it requires greater ambition, specificity, and implementation... AseBio
Rubén Pérez-Mañanes: “A public hospital can sustain a regulated, multidisciplinary and s... 14/05/2026 Healthcare Access to innovation Personalized medicine Rubén Pérez-Mañanes is an orthopaedic oncology surgeon at the HGUGM (Gregorio Marañón University General Hospital)... Partners - GENESIS Biomed
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemi... 13/05/2026 Healthcare Drug discovery Innovative drugs In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a... Partners - Oryzon Genomics
For the first time, four therapeutic genes have been inserted and one ‘unwanted’ gene rem... 12/05/2026 Healthcare Personalized medicine Advanced therapies These results come from a preclinical study conducted by the Cell Engineering team at Integra Therapeutics using the... Partners - Integra Therapeutics S.L.
Making Pharma Spain 2027 Barcelona Spain Del 17/02/2027 to 18/02/2027 Healthcare Innovative drugs Industrial biotechnology
Upcoming Webinar: The Art and Science of Cyclic Peptide Drug Design: From Experimental Dis... Del 27/05/2026 to 27/05/2026 Healthcare Drug discovery Innovative drugs International Digitalization
BCN HEALTH publishes a study evaluating the incidence, management, and associated costs of... 05/05/2026 Healthcare Innovative drugs Personalized medicine Partners - BCN Health
Institutional architecture for innovation in healthcare: talent, networks and translation... 04/05/2026 Healthcare Talento Innovation in healthcare does not arise solely from good ideas, but from an institutional architecture capable of... Partners - GENESIS Biomed
The IIBB-CSIC and Chemotargets promote the development of new therapies against cancer t... 29/04/2026 Healthcare Drug discovery Innovative drugs The agreement combines the preclinical models developed by the Institute of Biomedical Research of Barcelona (IIBB-CSIC)... Partners - Parc Científic de Barcelona
ORYZON to participate in upcoming events in May and June 29/04/2026 Healthcare Drug discovery Innovative drugs Updated data from iadademstat’s clinical trials in acute myeloid leukemia to be presented at EHA-2026 in June. Partners - Oryzon Genomics
